Primary study · included by 1 review

Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II).

Lynggaard 2022 (MESRIX-II) · Lynggaard Charlotte Duch, Grønhøj Christian, Christensen Robin, et al. · Stem cells translational medicine · 2022

Included by

Treatment of Xerostomia with Mesenchymal Stem Cells - A Systematic Review and Meta-Analysis of Clinical Trials.
Non-Cochrane · intervention · 2026 · cited as Lynggaard 2022 (MESRIX-II) · Results, Table 1; reference 23

The review does not say which of its outcomes this study informs.

1 including review in total.